Evaluation of current practices in transcatheter aortic valve implantation: The WRITTEN (WoRldwIde TAVI ExperieNce) survey.
暂无分享,去创建一个
T. Nazif | M. Leon | C. Macaya | F. Nietlispach | F. D’Ascenzo | E. Cerrato | L. Nombela‐Franco | P. Jiménez-Quevedo | J. Rodés‐Cabau | H. Eltchaninoff | P. D. de Jaegere | P. Agostoni | H. Ribeiro | C. Tamburino | M. Barbanti | L. Søndergaard | Mao Chen | O. Wendler | G. Maluenda | R. Trillo | Gabriel Maluenda
[1] G. de Simone,et al. A meta-analysis of the impact of pre-existing and new-onset atrial fibrillation on clinical outcomes in patients undergoing transcatheter aortic valve implantation. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[2] B. Iung,et al. TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation. , 2016, European heart journal.
[3] J. Leipsic,et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis , 2016, The Lancet.
[4] A. Regueiro,et al. Impact of New-Onset Left Bundle Branch Block and Periprocedural Permanent Pacemaker Implantation on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis , 2016, Circulation. Cardiovascular interventions.
[5] K. Alexander,et al. Gait Speed Predicts 30-Day Mortality After Transcatheter Aortic Valve Replacement: Results From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry , 2016, Circulation.
[6] M. Mack,et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. , 2016, The New England journal of medicine.
[7] S. Rex,et al. General or Local Anesthesia for TAVI? A Systematic Review of the Literature and Meta-Analysis. , 2016, Current pharmaceutical design.
[8] A. Regueiro,et al. Balancing the Risks of Thrombosis and Bleeding Following Transcatheter Aortic Valve Implantation: Current State-of-Evidence. , 2016, Current pharmaceutical design.
[9] R. Lange,et al. 1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study. , 2016, JACC. Cardiovascular interventions.
[10] J. Carroll,et al. Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry. , 2016, The Annals of thoracic surgery.
[11] N. Weissman,et al. Prospective Multicenter Evaluation of the Direct Flow Medical Transcatheter Aortic Valve System: 12-Month Outcomes of the Evaluation of the Direct Flow Medical Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis (DISCOVER) Study. , 2016, JACC. Cardiovascular interventions.
[12] J. Carroll,et al. Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry. , 2015, Journal of the American College of Cardiology.
[13] T. Lüscher,et al. Midregional Proadrenomedullin Improves Risk Stratification beyond Surgical Risk Scores in Patients Undergoing Transcatheter Aortic Valve Replacement , 2015, PloS one.
[14] C. Macaya,et al. Incidence, Causes, and Predictors of Early (≤30 Days) and Late Unplanned Hospital Readmissions After Transcatheter Aortic Valve Replacement. , 2015, JACC. Cardiovascular interventions.
[15] P. Leprince,et al. Baseline Characteristics and Prognostic Implications of Pre-Existing and New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Implantation: Results From the FRANCE-2 Registry. , 2015, JACC. Cardiovascular interventions.
[16] M. Mack,et al. Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER trial). , 2015, The American journal of cardiology.
[17] A. Colombo,et al. 5-Year Outcomes After Transcatheter Aortic Valve Implantation With CoreValve Prosthesis. , 2015, JACC. Cardiovascular interventions.
[18] L. W. Andersen,et al. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial. , 2015, Journal of the American College of Cardiology.
[19] R. Lange,et al. Perioperative Results and Complications in 15,964 Transcatheter Aortic Valve Replacements: Prospective Data From the GARY Registry. , 2015, Journal of the American College of Cardiology.
[20] B. Gage,et al. Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement , 2015, Heart.
[21] John D. Carroll,et al. Clinical outcomes at 1 year following transcatheter aortic valve replacement. , 2015, JAMA.
[22] P. Lemos,et al. Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death. , 2015, Journal of the American College of Cardiology.
[23] M. Mack,et al. Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement. , 2014, Journal of the American College of Cardiology.
[24] M. Mack,et al. The relative performance characteristics of the logistic European System for Cardiac Operative Risk Evaluation score and the Society of Thoracic Surgeons score in the Placement of Aortic Transcatheter Valves trial. , 2014, The Journal of thoracic and cardiovascular surgery.
[25] R. Jeger,et al. Pacemaker Implantation and Need for Ventricular Pacing during Follow‐Up after Transcatheter Aortic Valve Implantation , 2014, Pacing and clinical electrophysiology : PACE.
[26] Jeroen J. Bax,et al. Open issues in transcatheter aortic valve implantation. Part 2: procedural issues and outcomes after transcatheter aortic valve implantation. , 2014, European heart journal.
[27] Raimund Erbel,et al. Open issues in transcatheter aortic valve implantation. Part 1: patient selection and treatment strategy for transcatheter aortic valve implantation. , 2014, European heart journal.
[28] Tim Beißbarth,et al. Impact of frailty on short- and long-term morbidity and mortality after transcatheter aortic valve implantation: risk assessment by Katz Index of activities of daily living. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[29] Thoralf M Sundt,et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.
[30] Thoralf M Sundt,et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.
[31] M. Mack,et al. Predictors of Poor Outcomes After Transcatheter Aortic Valve Replacement: Results From the PARTNER (Placement of Aortic Transcatheter Valve) Trial , 2014, Circulation.
[32] Maurice Buchbinder,et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. , 2014, The New England journal of medicine.
[33] J. Mehilli,et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. , 2014, JAMA.
[34] A. Cheung,et al. Impact of new-onset persistent left bundle branch block on late clinical outcomes in patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve. , 2014, JACC. Cardiovascular interventions.
[35] Thoralf M Sundt,et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.
[36] J. Mega,et al. Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events. , 2013, Journal of the American College of Cardiology.
[37] M. Mack,et al. Relation between six-minute walk test performance and outcomes after transcatheter aortic valve implantation (from the PARTNER trial). , 2013, The American journal of cardiology.
[38] P. Pibarot,et al. Prognostic value of exercise capacity as evaluated by the 6-minute walk test in patients undergoing transcatheter aortic valve implantation. , 2013, Journal of the American College of Cardiology.
[39] M. Mack,et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, The Journal of thoracic and cardiovascular surgery.
[40] D. Wood,et al. Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. , 2012, Journal of the American College of Cardiology.
[41] M. Mack,et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, Journal of the American College of Cardiology.
[42] P. Jüni,et al. Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation. , 2012, JACC. Cardiovascular interventions.
[43] Cornelius Müller,et al. Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation. , 2012, Journal of the American College of Cardiology.
[44] P. Pibarot,et al. Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation. , 2012, Journal of the American College of Cardiology.
[45] Pascal Vranckx,et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, Journal of the American College of Cardiology.
[46] D. Capodanno,et al. Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation. , 2011, The American journal of cardiology.
[47] Stuart J Pocock,et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.
[48] Á. Cequier,et al. Atrioventricular Conduction Disturbance Characterization in Transcatheter Aortic Valve Implantation With the CoreValve Prosthesis , 2011, Circulation. Cardiovascular interventions.
[49] S. Pocock,et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.